SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®)

DRUG2 trials

Sponsors

University Hospital, Montpellier, Aswan University

Conditions

Chronic Heart FailurePASPSleep Apnea Syndrome

Phase 1

Effect of Sacubitril-Valsartan on Estimated Pulmonary Artery Systolic Pressure in Patients With Heart Failure With Reduced Ejection Fraction Heart Failure

CompletedNCT07814482

Aswan UniversityPASP

Start: 2025-07-05End: 2026-07-12Updated: 2026-09-11

Phase 4

Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study

CompletedNCT02916160

University Hospital, MontpellierChronic Heart Failure, Sleep Apnea Syndrome

Start: 2016-09-22End: 2020-02-27Updated: 2021-06-15

Related Papers

Sacubitril-Valsartan Initiation in Chronic Heart Failure Patients Impacts Sleep Apnea: The ENTRESTO-SAS Study

ESC Heart Failure2021-06-0833 citations